ES2147796T3 - Composicion para el tratamiento o la prevencion del herpes. - Google Patents

Composicion para el tratamiento o la prevencion del herpes.

Info

Publication number
ES2147796T3
ES2147796T3 ES94930239T ES94930239T ES2147796T3 ES 2147796 T3 ES2147796 T3 ES 2147796T3 ES 94930239 T ES94930239 T ES 94930239T ES 94930239 T ES94930239 T ES 94930239T ES 2147796 T3 ES2147796 T3 ES 2147796T3
Authority
ES
Spain
Prior art keywords
pct
herpes
prevention
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94930239T
Other languages
English (en)
Inventor
Christian-Georges Bidel
Jean Poirson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIDEL CHRISTIAN GEORGES
Original Assignee
BIDEL CHRISTIAN GEORGES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIDEL CHRISTIAN GEORGES filed Critical BIDEL CHRISTIAN GEORGES
Application granted granted Critical
Publication of ES2147796T3 publication Critical patent/ES2147796T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE AL MENOS UN PRINCIPIO ACTIVO DE LA FAMILIA DE LOS FLAVONOIDES PARA LA PREPARACION DE COMPOSICIONES DESTINADAS AL TRATAMIENTO Y/O A LA PREVENCION DEL HERPES.
ES94930239T 1993-10-07 1994-10-07 Composicion para el tratamiento o la prevencion del herpes. Expired - Lifetime ES2147796T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311951A FR2710844B1 (fr) 1993-10-07 1993-10-07 Composition pour le traitement ou la prévention de l'herpès.

Publications (1)

Publication Number Publication Date
ES2147796T3 true ES2147796T3 (es) 2000-10-01

Family

ID=9451624

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94930239T Expired - Lifetime ES2147796T3 (es) 1993-10-07 1994-10-07 Composicion para el tratamiento o la prevencion del herpes.

Country Status (11)

Country Link
US (1) US5849786A (es)
EP (1) EP0722325B1 (es)
AT (1) ATE193206T1 (es)
AU (1) AU7941294A (es)
DE (1) DE69424679T2 (es)
DK (1) DK0722325T3 (es)
ES (1) ES2147796T3 (es)
FR (1) FR2710844B1 (es)
GR (1) GR3034142T3 (es)
PT (1) PT722325E (es)
WO (1) WO1995009635A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG71877A1 (en) * 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
KR20000019716A (ko) * 1998-09-15 2000-04-15 박호군 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물
US6528042B1 (en) 1999-10-08 2003-03-04 Galileo Laboratories, Inc. Compositions of flavonoids for use as cytoprotectants and methods of making and using them
PT1750651T (pt) * 2003-12-18 2018-02-16 Nestec Sa Composição para melhorar a saúde da pele, cabelo e pelo contendo flavanonas
EP2353596A1 (en) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
MX354614B (es) * 2013-08-09 2018-03-08 Centro De Investig Y De Estudios Avanzados Del I P N Composición farmacéutica de diosmina y hesperidina y su uso en dolor neuropático.
FR3019820B1 (fr) * 2014-04-15 2017-07-21 Peter Weyts Composes de type flavonoides pour leur utilisation dans le traitement d'une pathologie du pied d'un mammifere ongule-composition pharmaceutique associee

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049798A (en) * 1974-12-11 1977-09-20 William K. Bottomley Method for the treatment of Herpes Simplex
WO1992015315A1 (en) * 1991-03-06 1992-09-17 Wilkinson Alfred H B Method for the treatment of herpes

Also Published As

Publication number Publication date
EP0722325B1 (fr) 2000-05-24
US5849786A (en) 1998-12-15
GR3034142T3 (en) 2000-11-30
FR2710844B1 (fr) 1995-12-29
ATE193206T1 (de) 2000-06-15
FR2710844A1 (fr) 1995-04-14
WO1995009635A1 (fr) 1995-04-13
AU7941294A (en) 1995-05-01
DK0722325T3 (da) 2000-10-02
DE69424679T2 (de) 2001-02-08
EP0722325A1 (fr) 1996-07-24
PT722325E (pt) 2000-10-31
DE69424679D1 (de) 2000-06-29

Similar Documents

Publication Publication Date Title
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ES2154336T3 (es) Producto para el cuidado de la piel.
ES2113635T3 (es) Aplicacion del riluzole en el tratamiento de lesiones neurologicas relacionadas con traumatismos.
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
FI972434A (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
ES2055415T3 (es) S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas.
AR015347A1 (es) Uso de colina para la preparacion de un medicamento o formulacion nutricional para el tratamiento del shock endotoxico y composiciones nutricionales quecomprenden colina
WO1996022305A3 (en) Modified peptides
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
BR9706891A (pt) Composto, medicamento, composição farmacêutica e composição cosmética.
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
SE8403659D0 (sv) Synergistic pharmaceutical composition
HU9202026D0 (en) Method and medical preparative for treatment of thrombocytopenie
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
ES2072005T3 (es) Utilizacion de analogos de 20(r)-22-oxa-vitamina d en la preparacion de un medicamento para el tratamiento del envejecimiento de la piel.
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
BR0116373A (pt) Utilização de tienilciclo-hexilamina, produto, e, composições farmacêuticas
IL108283A0 (en) Use of riluzole for promoting restoration following radiation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 722325

Country of ref document: ES